EUR/USD: MeVis Medical Solutions AG Revises FY 2025/26 Outlook

• MeVis Medical Solutions AG has revised its forecast for fiscal year 2025/2026 based on preliminary results.
• The company now expects revenue of €15.0–15.5 million, down from its previous forecast of €16.5–17.0 million.
• Revenue is expected to decline year over year.
• MeVis now forecasts negative EBIT of €1.0–1.5 million, compared with its prior expectation of positive EBIT of €0.5–1.0 million.
• The outlook assumes a stable exchange rate of USD 1.16 per euro.
• The revision is attributed to subdued mammography demand from customer Hologic and the persistently slow rollout of lung cancer screening in Germany.

The price of EUR/USD at the time of the news was 1,13650USD and was down -0,53 % compared with the previous day.
15 minutes after the article was published, the price was 1,13675USD this corresponds to a plus of +0,02 % since publication.

EUR/USD

-0,08 %

-1,13 %

-3,38 %

-2,02 %

-4,22 %

+5,94 %

-2,93 %

+0,62 %

+16,32 %

ISIN:EU0009652759WKN:965275

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max

Prämie Jetzt bis zu 120 € Prämie sichern! Egal ob Trading, Sparen oder beides - bei SMARTBROKER+ ist für alle was dabei. Jetzt Depot eröffnen und sichern!

Schreibe Deinen Kommentar